IntriCon (NASDAQ:IIN) issued its quarterly earnings results on Monday. The technology company reported $0.07 earnings per share for the quarter, beating analysts’ consensus estimates of $0.06 by $0.01, Bloomberg Earnings reports. IntriCon had a negative net margin of 0.63% and a positive return on equity of 4.06%.
IntriCon (IIN) traded up $0.50 on Monday, reaching $18.15. 47,046 shares of the company’s stock were exchanged, compared to its average volume of 90,301. The company has a quick ratio of 0.54, a current ratio of 1.45 and a debt-to-equity ratio of 0.34. IntriCon has a 12-month low of $6.05 and a 12-month high of $24.00. The firm has a market cap of $124.67, a price-to-earnings ratio of 86.43, a PEG ratio of 1.47 and a beta of 0.21.
A number of analysts have commented on the stock. Zacks Investment Research raised shares of IntriCon from a “hold” rating to a “strong-buy” rating and set a $23.00 target price for the company in a report on Wednesday, January 3rd. TheStreet raised shares of IntriCon from a “c” rating to a “b-” rating in a report on Wednesday, November 8th. Two research analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the stock. IntriCon has an average rating of “Buy” and an average price target of $17.00.
An institutional investor recently raised its position in IntriCon stock. Northern Trust Corp boosted its stake in IntriCon Co. (NASDAQ:IIN) by 10.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,040 shares of the technology company’s stock after acquiring an additional 1,942 shares during the quarter. Northern Trust Corp owned 0.31% of IntriCon worth $172,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 31.45% of the company’s stock.
IntriCon Corporation is engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. The Company operates through body-worn device segment. The Company serves the body-worn device market by designing, developing, engineering and manufacturing micro-miniature products, microelectronics, micro-mechanical assemblies, complete assemblies and software solutions, primarily for the value hearing health market, the medical bio-telemetry market and the professional audio communication market.
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.